Variant report
Variant | esv3341264 |
---|---|
Chromosome Location | chr15:49663460-49664908 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:13)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:13 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr15:49664840-49664990 | BE2_C | brain: | n/a | n/a |
2 | CTCF | chr15:49662839-49663528 | SK-N-SH | brain: | n/a | chr15:49663197-49663215 chr15:49663199-49663220 chr15:49663198-49663214 |
3 | CTCF | chr15:49663038-49663522 | HCT-116 | colon: | n/a | chr15:49663197-49663215 chr15:49663199-49663220 chr15:49663198-49663214 |
4 | GATA3 | chr15:49664857-49665050 | SH-SY5Y | brain: | n/a | n/a |
5 | JUN | chr15:49663453-49663495 | K562 | blood: | n/a | n/a |
6 | MAX | chr15:49664740-49664901 | H1-hESC | embryonic stem cell: | n/a | n/a |
7 | MXI1 | chr15:49664684-49664862 | H1-hESC | embryonic stem cell: | n/a | n/a |
8 | POU5F1 | chr15:49664633-49665018 | H1-hESC | embryonic stem cell: | n/a | chr15:49664787-49664796 chr15:49664785-49664796 chr15:49664785-49664794 |
9 | RAD21 | chr15:49662812-49663641 | SK-N-SH | brain: | n/a | chr15:49663198-49663217 |
10 | SIN3A | chr15:49664647-49664784 | H1-hESC | embryonic stem cell: | n/a | n/a |
11 | STAT3 | chr15:49663094-49663504 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | USF1 | chr15:49664709-49664909 | H1-hESC | embryonic stem cell: | n/a | n/a |
13 | ZNF143 | chr15:49664647-49664683 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000259531 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs199971746 | chr15:49663506-49663507 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs147388904 | chr15:49663514-49663515 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs200397296 | chr15:49663534-49663535 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs143135128 | chr15:49663547-49663548 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs538375897 | chr15:49663548-49663549 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs375798990 | chr15:49663553-49663554 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs369064258 | chr15:49663583-49663584 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs371981118 | chr15:49663587-49663588 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs145082626 | chr15:49663592-49663593 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs375286606 | chr15:49663632-49663633 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs537970945 | chr15:49663684-49663685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs370455293 | chr15:49663698-49663699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs571776339 | chr15:49663764-49663765 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs542609267 | chr15:49663772-49663773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs552486559 | chr15:49663787-49663788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs565883861 | chr15:49663791-49663792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs71467675 | chr15:49663803-49663804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs12908698 | chr15:49663804-49663805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs12908709 | chr15:49663814-49663815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs560715733 | chr15:49663836-49663837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs577943963 | chr15:49663838-49663839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs192969859 | chr15:49663842-49663843 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs185594682 | chr15:49663868-49663869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs190271278 | chr15:49663883-49663884 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565505912 | chr15:49663901-49663902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs181962658 | chr15:49663924-49663925 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs547975507 | chr15:49663948-49663949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs559664727 | chr15:49663956-49663957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs185144227 | chr15:49663982-49663983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs374448636 | chr15:49664008-49664009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs368653064 | chr15:49664034-49664035 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs369059759 | chr15:49664054-49664055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs188286895 | chr15:49664081-49664082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs71992793 | chr15:49664113-49664114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs181260338 | chr15:49664126-49664127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186501808 | chr15:49664128-49664129 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs373266267 | chr15:49664157-49664158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs200889950 | chr15:49664163-49664164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs201121352 | chr15:49664189-49664190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs139607223 | chr15:49664215-49664216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs149745620 | chr15:49664241-49664242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs111217953 | chr15:49664253-49664254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs191761864 | chr15:49664258-49664259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs62637730 | chr15:49664267-49664268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs111556158 | chr15:49664279-49664280 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs183323989 | chr15:49664284-49664285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs187037403 | chr15:49664293-49664294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs190737974 | chr15:49664310-49664311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs183249322 | chr15:49664319-49664320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs71394973 | chr15:49664336-49664337 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Schizophrenia | 19415332 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
cataract | 16735990 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 21979893 | CNVD |
spastic paraplegia with thinning of corpus callosum | 19105190 | CNVD |
Schizophrenia | 21324950 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Disease | 21824424 | CNVD |
Melanoma | 18172304 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Gastric cancer | 17167181 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Intellectual disability | 22102821 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21785460 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Breast cancer | 22032731 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Cancer | 21129771 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 21364760 | CNVD |
Aromatase excess syndrome | 21470988 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr15:49662000-49664600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
2 | chr15:49662800-49664600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr15:49663400-49663600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr15:49663400-49664400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr15:49663600-49664600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
6 | chr15:49664400-49665000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr15:49664400-49665200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr15:49664400-49665200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr15:49664400-49665200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr15:49664400-49665600 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
11 | chr15:49664600-49665000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
12 | chr15:49664600-49665000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
13 | chr15:49664600-49665000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
14 | chr15:49664600-49665000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
15 | chr15:49664600-49665000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
16 | chr15:49664600-49665200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
17 | chr15:49664600-49665200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
18 | chr15:49664600-49665200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |